AI assistant
Sending…
PLUS THERAPEUTICS, INC. — Director's Dealing 2018
Feb 14, 2018
34301_dirs_2018-02-14_15083efb-413e-4c8b-9e7d-790d815fb292.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2018-02-12
Reporting Person: PostFinance AG (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-02-12 | Common Stock | S | 185272 | $0.3148 | Disposed | 5118627 | Direct |
| 2018-02-13 | Common Stock | S | 101710 | $0.3112 | Disposed | 5016917 | Direct |
More from PLUS THERAPEUTICS, INC.
Capital/Financing Update
2026
Jun 5
Regulatory Filings
2026
Jun 5
Capital/Financing Update
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
Apr 21
Board/Management Information
2026
Apr 9
Regulatory Filings
2026
Apr 8
Board/Management Information
2026
Mar 26